Related Experiment Video
Updated: May 8, 2025
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
A Firing Cannon: Bilateral Lower Limb Ischemia as a Manifestation of Cardiac Myxoma
Mohamed Elbayomi1, Raphael Groß1, Pathare Presheet1
1Department of Cardiac Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Insights
Cardiac myxomas, tumors in the heart, can cause dangerous embolisms. This case highlights the risk of limb ischemia and questions the optimal timing for surgical intervention in myxoma patients.
Area of Science:
- Cardiology
- Oncology
Background:
- Cardiac myxomas are the most common primary cardiac tumors.
- These neoplasms can lead to serious complications if not managed promptly.
Observation:
- A middle-aged woman with a left atrial myxoma awaiting surgery presented with emergent bilateral lower limb ischemia.
- The embolic event fortunately affected a tissue with high ischemia tolerance.
Findings:
- The case demonstrates a potentially life-threatening embolic complication from a cardiac myxoma.
- Prompt surgical intervention may be crucial to prevent severe outcomes like stroke.
Implications:
- This case raises important questions regarding the optimal timing for surgical management of cardiac myxomas.
- Early surgical intervention is critical to prevent catastrophic embolic events and improve patient outcomes.
Abstract:
Background Cardiac myxomas are the most common primary cardiac neoplasms. Case Description We present a case of a middle-aged lady with cardiac myxoma in her left atrium awaiting semi-elective surgery. During the preoperative period, the patient presented emergently with acute bilateral lower limb ischemia. This lady was fortunate to have these emboli fired towards a tissue with ischemia tolerance capacity. If these emboli had been directed toward the central nervous system, this patient would have experienced devastating complications and even death. Conclusion This presentation opens the debate on the timing of surgical intervention in myxoma patients.
